Continued Strong 2026 Outlook Enhanced by Acquisition of Sommer Ray’s Imaraïs Beauty, Delivering Major National B2B Customer Wins
LAS VEGAS, NV / ACCESS Newswire / August 6, 2026 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical formulations and precision dose gummy manufacturing, expects to report another period of record revenues for the second quarter and first half ended June 30, 2026.
Second quarter 2026 net revenue is expected to exceed a record $2.0 million, up more than 112% sequentially and 129% versus the same year-ago quarter.
The growth is expected to drive 2026 first half net revenues to exceed a record $3.6 million, up more than 93% compared to the first half of 2025 and keep the company on track for another year of double-digit revenue growth.
The strong topline performance was largely due to the synergistic merger with Gummy USA™ in October 2025 and the acquisition of Imaraïs Beauty in May of this year. Both added new product lines, expanded distribution channels, and generated new B2B customers.
Q2 2026 Operational Highlights
-
In April, Healthy Extracts’ wholly owned subsidiary, Gummy USA, entered a U.S. manufacturing partnership with Imaraïs Beauty, the popular plant-based ingestible beauty and wellness brand founded by media personality, Sommer Ray, and award-winning supplement industry veteran, Aaron Hefter. Imaraïs has broad distribution across major U.S. retail channels, including Target, Ulta Beauty and Sprouts, as well as numerous international outlets.
-
Imarais Beauty partnership launched with an initial large order totaling nearly 4 million gummies across five existing Imaraïs Beauty SKUs. The order has begun shipping to more than 4,000 store locations nationwide that include highly visible isle end-cap placements.
-
In May, the new partnership with Imarais Beauty transformed into its acquisition by Healthy Extracts, resulting in Imarais Beauty becoming a new wholly owned operating subsidiary. Since its founding in 2020, Imaraïs Beauty has attracted worldwide acclaim and countless loyal customers and social media influencers, with the brand sold worldwide through thousands of retailer locations and online. Imaraïs Beauty’s phenomenal success has been featured across major publications, including WWD, Forbes, Beauty Independent, and Entrepreneur.
-
The transformative strategic merger last fall with Gummy USA has continued to address the unmet need in the nutraceutical and pharmaceutical industry for precision-dosed gummy manufacturing technology, with this opening the door to new specialized B2B product development.
Management Commentary
“In Q2 2006, we generated another quarter of record-setting revenues and market expansion,” stated Healthy Extracts CEO, Don Swanson. “In fact, it was our ninth consecutive quarter of year-over-year revenue growth.
“This strong topline performance reflects our continued evolution into an industry leader in nutraceutical innovation. The integration of Gummy USA, along with now the addition of Imarais Beauty, has accelerated our technological development and expanded our product lines and addressable market. This has resulted in new B2B, direct-to-consumer and retail sales.
“During the quarter, we continued to focus on our long-term strategic growth strategies. This includes achieving superior leadership in formulation and manufacturing technologies that target the high-growth, high-margin Nutra Pharma and Health & Beauty sectors.
“Today, we enjoy vast opportunities where we can leverage our strengths in advanced formulations, manufacturing, and proprietary delivery technologies. We expect these efforts to benefit from the strong industry growth in our health and beauty category which is expected to top $730 billion this year. We also see many great opportunities in the broader health and wellness markets.
“Our Gummy USA’s new U.S. manufacturing partnership with Imaraïs Beauty that we announced in the second quarter quickly evolved into their acquisition. Their proprietary technology and advanced formulations are unlike anything I’ve seen in the gummy market today. Our precision dosing technology aligns perfectly with their commitment to premium quality, innovation, and rapid global market expansion.
“We expect Imaraïs’ existing market reach and retail momentum to accelerate our gummy manufacturing output for the remainder of the year and open the door to many new opportunities. To be sure, this is not only for beauty and wellness, but also in pioneering the next generation of functional and OTC gummy delivery systems across multiple categories within the large consumer health market.
“We see the initial large Imaraïs Beauty order for nationwide retail distribution is just the beginning of a highly scalable, transformational growth phase for Healthy Extracts and Gummy USA. By leveraging our advanced U.S. manufacturing capabilities, we have tremendous opportunities to rapidly expand the Imaraïs brand worldwide.
“Given our current commercial initiatives, which includes extensive new B2B customer engagement and product development, we continue to believe we have the potential to achieve annualized net revenue of more than $20 million by year end-or up more than 3x over last year. While this aspirational goal is aggressive, we believe it is supported by our current sales pipeline and existing manufacturing and distribution capacity.
“Key to this success will be our unique precision dose manufacturing capabilities and exclusive licensed delivery systems. We believe these two factors provide exceptional differentiation within our Nutraceutical, Nutra Pharma and Functional Wellness markets, and they have set the stage for an exceptionally strong period ahead for Healthy Extracts.
“The Gummy USA merger and Imaraïs Beauty acquisition have come during a period of increased investor interest and consolidation within the gummy and wellness sector. Many high-profile industry deals, such as the recent $1.2 billion acquisition of Grüns Gummies by Unilever, highlight the significant market demand for scalable wellness brands that possess strong consumer engagement, differentiated product positioning, and growing retail distribution.
“As we look to the second half of the year, our mission is clear: build one of the most trusted, innovative, and respected health, wellness, and beauty companies in the world, while delivering sustainable long-term value to our stakeholders.”
About Healthy Extracts “Live Life Young Again”
Healthy Extracts Inc. (OTCQB:HYEX) is a leader in nutraceutical innovation, precision-dose oral delivery systems, and functional wellness consumer brands. The company develops, manufactures, and markets science-based products focused on beauty, wellness, brain, heart, gut, and lifestyle health through proprietary formulations, advanced delivery technologies, and scalable national retail distribution.
Through its acquisition of Imaraïs Beauty, the celebrity-founded ingestible beauty and wellness brand co-founded by Sommer Ray and entrepreneur Aaron Hefter, Healthy Extracts has significantly expanded its position within the rapidly growing global beauty and personal care market. Imaraïs Beauty combines advanced functional beauty formulations with strong consumer engagement, influencer-driven branding, and expanding global retail distribution across major retail, including Target, Ulta Beauty, Nordstrom, and Sprouts, and international markets.
Healthy Extracts’ wholly owned subsidiary, Gummy USA™, is a leading developer and manufacturer of precision-dosed nutraceutical and pharmaceutical-grade gummies. Proprietary, patent-pending SureDose™ technology is designed to deliver superior dosing accuracy, safety, efficacy, and consumer compliance for both company-owned and partner brands.
The company’s portfolio also includes BergametNA™ and Ultimate Brain Nutrients™ (UBN™) which offer science-backed supplements supporting cardiovascular and cognitive health. Healthy Extracts additionally maintains exclusive agreements for innovative oral delivery technologies, including Gelteq gel delivery systems and the Gut Health Straw platform, which are designed to improve bioavailability and consumer convenience.
To learn more, visit Healthy Extracts Inc., Imaraïs Beauty, BergametNA, Ultimate Brain Nutrients, or Gummy USA.
Safe Harbor Notice and Important Cautions Regarding Forward-Looking Statements
The preliminary unaudited results presented in this press release are estimates only and are subject to revision until the company officially reports its full second quarter results and files it Form 10-Q with the U.S. Securities and Exchange Commission (SEC).
All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 8, 2026, and future periodic reports filed with the U.S. Securities and Exchange Commission (SEC). All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only to the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Food & Drug Administration Disclosure
The products and formulations featured in this release are not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor’s advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
Gummy USA ™, BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are trademarks and registered trademarks of Healthy Extracts™ Inc.
Company Contact
Don Swanson, CEO
Healthy Extracts Inc.
Tel (801) 232-0753
don@gummyusa.com
Investor Contact
CMA Investor Relations
Tel (949) 432-7554
https://www.capitalmarketaccess.com/contact
SOURCE: HEALTHY EXTRACTS INC.
View the original press release on ACCESS Newswire
Media gallery
